Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Alnylam, Stock Offerings, Curis, & More 01/23/15 Boston
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More 04/04/14 Boston
FDA Lifts Clinical Hold on Curis Cancer Drug, Shares Surge 03/31/14 Boston
East Coast Biotech Roundup: Arno, Accelerate LI, Immunogen, & More 11/08/13 Boston
Curis Shares Tumble As Cancer Drug Slapped With FDA Clinical Hold 11/06/13 Boston
FDA Approvals for Alkermes & Vertex Among the NE Life Sciences News 02/03/12 Boston
FDA Gives Thumbs-Up to Skin Cancer Drug from Genentech and Curis 01/30/12 Boston
Genentech Seeks FDA Clearance for Next Skin Cancer Drug 09/12/11 San Francisco
Curis and Genentech Unleash the Hedgehog to Fight a Deadly Skin Cancer 06/28/11 Boston
Biogen Eyes Cambridge Move, Vertex Licenses Alios Drugs, Concert Nabs GSK Payment, & More Boston-Area Life Sciences News 06/24/11 Boston
Genentech, Curis Pass Clinical Trial With Skin Cancer Drug, Look Ahead to FDA 06/20/11 San Francisco
Alnylam Sued By Tekmira, Curis Cancer Drug Shows Results, Still River Gets $11.5M, & More Boston-Area Life Sciences News 03/25/11 Boston
Genentech Gets Positive Result in Cancer Trial 03/21/11 Boston
Curis Misses Mark in Cancer Drug Trial, Genzyme Re-Elects Full Board, GTC Cuts Jobs, & More Boston-Area Life Sciences News 06/18/10 Boston
Curis Stock Tanks After Cancer Drug Fails in Roche, Genentech’s Hands 06/16/10 Boston
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten 10/08/09 Boston
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter 03/17/09 Boston
Curis Gets $3M From Genentech For Ovarian Cancer Trial Initiation 12/08/08 Boston
Hold on Tight: Biotech Execs Predict Hard Times for Industry as Cash Dwindles 11/25/08 National
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter 11/25/08 Boston
Curis Begins Phase 1 Trial of Anti-Tumor Drug 08/26/08 Boston
Concert Strikes a Chord With Investors, Abiomed Scores a Win with Medicare, Epix Snags $7.5M from GSK, & More Life Sciences News 05/07/08 Boston
Let the Epic Curing Begin: Epix and Curis Earn Milestone Payments 05/05/08 Boston
Exact Sciences Makes the List, Curis and Alkermes Get Dropped, Patent Reform Sparks Debate, & More Life Sciences News 03/12/08 Boston
Curis, Alkermes Down on News of Failed Pharma Partnerships 03/10/08 Boston
Cleaning the Slate, Raising Funds, and Filling the Executive Suite 08/13/07 Boston
Page 1 of 1